Pfizer, BioNTech to start clinical trials for omicron vaccine
SAN FRANCISCO (KRON) -- Pfizer and its partner BioNTech are starting clinical trials for an omicron variant-specific COVID-19 vaccine for adults ages 18-55, the companies announced…
SAN FRANCISCO (KRON) -- Pfizer and its partner BioNTech are starting clinical trials for an omicron variant-specific COVID-19 vaccine for adults ages 18-55, the companies announced…